There is a strange thing about how clinical trials find patients in this country. A sponsor needs 400 people with moderate psoriasis. A dedicated research facility gets the study, then spends months and a serious ad budget convincing strangers with psoriasis to drive to a building they have never seen, to be treated by a doctor they have never met.
Meanwhile, three miles away, a dermatologist has been treating 1,200 psoriasis patients for fifteen years. They trust her. They show up. She knows which of them have failed two biologics and which ones would jump at a new option.
The industry calls the first building a research site. We think the second one is.
What embedded actually means
At Stryde, we do not ask physicians to become research operators, and we do not ask patients to go anywhere new. We place a trained clinical research coordinator inside the practice, on our payroll. Our central team handles regulatory documents, quality, startup, and finance. The physician serves as Principal Investigator for their own patients, in their own exam rooms.
The results are not mysterious. When the eligible patients are already in the EMR and already trust the investigator, startup runs about 30% faster than industry norms and enrollment about 40% faster. There is no recruitment funnel to build because the funnel is the practice.
The part nobody talks about
Retention is where this model quietly wins. A patient who joined a study through a stranger’s ad has no relationship holding them there when visit twelve gets inconvenient. A patient whose own doctor is running the study has a decade of trust in the room. Our visit window adherence runs above 90% because showing up for research feels like showing up for a regular appointment. It is one.
If you are a sponsor tired of site lists that look identical, or a physician who always wondered about research but never wanted the second job, that is exactly the gap we built Stryde to close.